88 89 90 91 92

Press Photos

Please note our terms of use governing the use of press images.By downloading the images from our media database, you agree to these terms of use: Press images may only be used for press purposes (print, electronic media, online) and exclusively in the context of the associated press release and may not be edited. The picture credits (source: Wacker Chemie AG) are mandatory. Images deleted from the media database may no longer be used in the future. If a press photo is used, a copy of the publication or a link to the publication is requested. Otherwise, the copyright information www.wacker.com/disclaimer applies.

Wacker Biotech Amsterdam

Through its 2018 acquisition of SynCo Bio Partners B.V. in Amsterdam, the Netherlands, Wacker Chemie AG strengthened its pharmaceutical protein business and expanded its portfolio – an important step to keep pace with the rapidly growing biologics market. As a result, Wacker Biotech now has three sites: Jena, Halle and Amsterdam, with a total of about 330 employees. (Photo: Wacker Chemie AG)

Download picture (JPG, 2.8 MB)

Wacker Biotech Lab

Specialists in the field of microbial production: Wacker Biotech GmbH is a full-service contract manufacturer of biologics with more than 20 years of experience with microbial systems. The company’s core competencies include the manufacture of active pharmaceutical ingredients, vaccines and live bacteria. (Photo: Wacker Chemie AG)

Download picture (JPG, 494 KB)

Wacker Biotech Fermenter

Production at Wacker Biotech GmbH: the Munich-based WACKER Group entered the field of contract manufacturing for pharmaceutical proteins when it acquired Prothera GmbH and subsequently renamed it Wacker Biotech in 2005. (Photo: Wacker Chemie AG)

Download picture (JPG, 333 KB)